Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5909
|
pubmed:dateCreated |
1974-6-5
|
pubmed:abstractText |
Rat hearts with coronary circulations perfused by the Langendorff technique were studied. Recordings were made of the electrical and mechanical activity. Once the rate and rhythm of each heart and stabilized it was perfused with Ringer-Locke solution for 90 minutes; frusemide (40 mug/ml) was added to the perfusate during the last 30 minutes of this period. Eighteen experiments were performed-six controls, six in which prolactin at a concentration of 50 ng/ml was added to the perfusate for the whole 90 minutes, and six in which a prolactin concentration of 200 ng/ml was used.With the controls heart rate and rhythm remained steady, but there was a slow decline in amplitude of the contraction. With a prolactin concentration of 50 ng/ml the heart rate rose to about 40% above control during the first hour and after an initial sharp increase the contraction amplitude declined more rapidly than in the controls. The prolactin concentration of 200 ng/ml produced a decline of about 25% in heart rate over the first hour and amplitude behaved much as in the controls. Frusemide had no clear effect on the rate of beating of the controls, but it tended to reverse both the acceleration produced by 50 ng/ml prolactin and the slowing produced by the higher dose. Both the doses of prolactin consistently caused disturbances of rhythm. These effects occur at concentration of prolactin found in human plasma in various pathophysiological conditions.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-13025687,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-14045347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-4127278,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-4128582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-4195548,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-4403825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-4569233,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-5478509,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-5694867,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4821039-5712346
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0007-1447
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
27-9
|
pubmed:dateRevised |
2010-10-26
|
pubmed:meshHeading |
pubmed-meshheading:4821039-Animals,
pubmed-meshheading:4821039-Arrhythmias, Cardiac,
pubmed-meshheading:4821039-Electrocardiography,
pubmed-meshheading:4821039-Electrophysiology,
pubmed-meshheading:4821039-Furosemide,
pubmed-meshheading:4821039-Heart,
pubmed-meshheading:4821039-Heart Rate,
pubmed-meshheading:4821039-Perfusion,
pubmed-meshheading:4821039-Prolactin,
pubmed-meshheading:4821039-Rats
|
pubmed:year |
1974
|
pubmed:articleTitle |
Actions of prolactin and frusemide on heart rate and rhythm.
|
pubmed:publicationType |
Journal Article,
In Vitro
|